[IRANNOTICE] Medtronic plc SEC Filing
Medtronic plc (MDT) has delivered a routine notice to the U.S. Securities and Exchange Commission stating that its Annual Report on Form 10-K for the fiscal year ended April 25, 2025, filed on June 20, 2025, contains disclosure made under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act. The letter, signed by Vice President, Global Controller and Chief Accounting Officer Denise L. Blomquist, fulfills the statutory requirement to alert the SEC of any Iran-related activities discussed in the 10-K. No quantitative details or descriptions of the underlying transactions are provided in this notice, leaving investors to consult the full 10-K for specifics.
Medtronic plc (MDT) ha inviato una comunicazione ordinaria alla U.S. Securities and Exchange Commission, dichiarando che il suo Rapporto Annuale sul Modulo 10-K per l'esercizio chiuso al 25 aprile 2025, depositato il 20 giugno 2025, include informazioni fornite ai sensi della Sezione 219 dell'Iran Threat Reduction and Syria Human Rights Act del 2012 e della Sezione 13(r) dell'Exchange Act. La lettera, firmata dalla Vicepresidente, Controller Globale e Chief Accounting Officer Denise L. Blomquist, soddisfa l'obbligo legale di informare la SEC di qualsiasi attivit脿 correlata all'Iran menzionata nel 10-K. Questa comunicazione non contiene dettagli quantitativi n茅 descrizioni delle transazioni sottostanti, invitando gli investitori a consultare il 10-K completo per maggiori dettagli.
Medtronic plc (MDT) ha presentado un aviso rutinario a la Comisi贸n de Bolsa y Valores de EE. UU. indicando que su Informe Anual en el Formulario 10-K para el a帽o fiscal finalizado el 25 de abril de 2025, presentado el 20 de junio de 2025, incluye divulgaciones realizadas bajo la Secci贸n 219 de la Ley de Reducci贸n de Amenazas de Ir谩n y Derechos Humanos en Siria de 2012 y la Secci贸n 13(r) de la Ley de Intercambio. La carta, firmada por la Vicepresidenta, Controladora Global y Directora de Contabilidad Denise L. Blomquist, cumple con el requisito legal de alertar a la SEC sobre cualquier actividad relacionada con Ir谩n mencionada en el 10-K. Este aviso no proporciona detalles cuantitativos ni descripciones de las transacciones subyacentes, por lo que se invita a los inversores a consultar el 10-K completo para obtener detalles espec铆ficos.
Medtronic plc (MDT)電� 2025雲� 4鞗� 25鞚� 膦呺霅� 須岅硠鞐半弰鞐� 雽�頃� 鞐半氤搓碃靹�(Form 10-K)毳� 2025雲� 6鞗� 20鞚� 氙戈淡 歃濌秾瓯半灅鞙勳洂須�(SEC)鞐� 鞝滌稖頃橂┌, 頃措嫻 氤搓碃靹滌棎 2012雲� 鞚措瀫 鞙勴槕 臧愳唽 氚� 鞁滊Μ鞎� 鞚戈秾氩� 靹轨厴 219 氚� 歃濌秾瓯半灅氩� 靹轨厴 13(r)鞐� 霐半ジ 瓿奠嫓臧� 韽暔霅橃柎 鞛堨潓鞚� 鞎岆Μ電� 鞝曣赴 韱奠毳� 鞝勲嫭頄堨姷雼堧嫟. 鞚� 靹滍暅鞚� 攵�靷灔 瓴� 旮�搿滊矊 旎姼搿る煬 氚� 斓滉碃須岅硠毂呾瀯鞛愳澑 Denise L. Blomquist臧� 靹滊獏頄堨溂氅�, 10-K鞐� 鞏戈笁霅� 鞚措瀫 甏�霠� 頇滊彊鞐� 雽�頃� SEC鞐� 鞎岆Μ電� 氩曥爜 鞚橂毳� 鞚错枆頃╇媹雼�. 鞚� 韱奠鞐愲姅 甑泊鞝侅澑 靾橃箻雮� 瓯半灅 雮挫棴 靹る獏鞚� 韽暔霅橃柎 鞛堨 鞎婌晞 韴瀽鞛愲摛鞚� 鞛愳劯頃� 雮挫毄鞚� 頇曥澑頃橁赴 鞙勴暣 鞝勳泊 10-K 氤搓碃靹滊ゼ 彀胳“頃挫暭 頃╇媹雼�.
Medtronic plc (MDT) a adress茅 une notification de routine 脿 la Securities and Exchange Commission des 脡tats-Unis, indiquant que son rapport annuel sur le formulaire 10-K pour l'exercice clos le 25 avril 2025, d茅pos茅 le 20 juin 2025, contient des informations divulgu茅es conform茅ment 脿 la section 219 de l'Iran Threat Reduction and Syria Human Rights Act de 2012 et 脿 la section 13(r) de l'Exchange Act. La lettre, sign茅e par la vice-pr茅sidente, contr么leur mondial et directrice comptable Denise L. Blomquist, remplit l'obligation l茅gale d'informer la SEC de toute activit茅 li茅e 脿 l'Iran mentionn茅e dans le 10-K. Cette notification ne fournit aucun d茅tail quantitatif ni description des transactions sous-jacentes, invitant les investisseurs 脿 consulter le rapport 10-K complet pour plus de pr茅cisions.
Medtronic plc (MDT) hat der US-B枚rsenaufsichtsbeh枚rde SEC eine routinem盲脽ige Mitteilung 眉bermittelt, in der angegeben wird, dass der Jahresbericht auf Formular 10-K f眉r das am 25. April 2025 endende Gesch盲ftsjahr, eingereicht am 20. Juni 2025, Angaben gem盲脽 Abschnitt 219 des Iran Threat Reduction and Syria Human Rights Act von 2012 sowie Abschnitt 13(r) des Exchange Act enth盲lt. Das Schreiben, unterzeichnet von Vizepr盲sidentin, Global Controller und Chief Accounting Officer Denise L. Blomquist, erf眉llt die gesetzliche Verpflichtung, die SEC 眉ber etwaige im 10-K diskutierte Iran-bezogene Aktivit盲ten zu informieren. Diese Mitteilung enth盲lt keine quantitativen Details oder Beschreibungen der zugrunde liegenden Transaktionen, weshalb Investoren aufgefordert werden, den vollst盲ndigen 10-K-Bericht f眉r Einzelheiten zu konsultieren.
- None.
- The filing acknowledges Iran-related activities, introducing potential regulatory, sanctions, or reputational risks pending further detail.
Insights
TL;DR Routine 13(r) filing flags potential Iran exposure; lack of detail implies modest but monitor-worthy compliance risk.
The filing is a statutory formality triggered whenever an issuer reports Iran-related dealings in its periodic reports. Although the notice itself is short, its presence confirms that some level of activity, however minor, required disclosure under Section 13(r). This raises possible sanctions and reputational considerations until investors can gauge scope and materiality in the 10-K. Absent specifics, probability of a severe penalty appears low, yet ongoing compliance monitoring is prudent for stakeholders.
TL;DR Standard notification; impact neutral unless 10-K reveals material revenue or penalties.
From a portfolio standpoint, this notice alone does not change the investment thesis. Large multinationals routinely file 13(r) notices for de minimis or legacy transactions. Without figures, cash鈥恌low sensitivity or regulatory fines cannot be assessed. I will review the Form 10-K to confirm whether the Iran-related activities are immaterial or require position sizing adjustments, but for now I treat the disclosure as procedural.
Medtronic plc (MDT) ha inviato una comunicazione ordinaria alla U.S. Securities and Exchange Commission, dichiarando che il suo Rapporto Annuale sul Modulo 10-K per l'esercizio chiuso al 25 aprile 2025, depositato il 20 giugno 2025, include informazioni fornite ai sensi della Sezione 219 dell'Iran Threat Reduction and Syria Human Rights Act del 2012 e della Sezione 13(r) dell'Exchange Act. La lettera, firmata dalla Vicepresidente, Controller Globale e Chief Accounting Officer Denise L. Blomquist, soddisfa l'obbligo legale di informare la SEC di qualsiasi attivit脿 correlata all'Iran menzionata nel 10-K. Questa comunicazione non contiene dettagli quantitativi n茅 descrizioni delle transazioni sottostanti, invitando gli investitori a consultare il 10-K completo per maggiori dettagli.
Medtronic plc (MDT) ha presentado un aviso rutinario a la Comisi贸n de Bolsa y Valores de EE. UU. indicando que su Informe Anual en el Formulario 10-K para el a帽o fiscal finalizado el 25 de abril de 2025, presentado el 20 de junio de 2025, incluye divulgaciones realizadas bajo la Secci贸n 219 de la Ley de Reducci贸n de Amenazas de Ir谩n y Derechos Humanos en Siria de 2012 y la Secci贸n 13(r) de la Ley de Intercambio. La carta, firmada por la Vicepresidenta, Controladora Global y Directora de Contabilidad Denise L. Blomquist, cumple con el requisito legal de alertar a la SEC sobre cualquier actividad relacionada con Ir谩n mencionada en el 10-K. Este aviso no proporciona detalles cuantitativos ni descripciones de las transacciones subyacentes, por lo que se invita a los inversores a consultar el 10-K completo para obtener detalles espec铆ficos.
Medtronic plc (MDT)電� 2025雲� 4鞗� 25鞚� 膦呺霅� 須岅硠鞐半弰鞐� 雽�頃� 鞐半氤搓碃靹�(Form 10-K)毳� 2025雲� 6鞗� 20鞚� 氙戈淡 歃濌秾瓯半灅鞙勳洂須�(SEC)鞐� 鞝滌稖頃橂┌, 頃措嫻 氤搓碃靹滌棎 2012雲� 鞚措瀫 鞙勴槕 臧愳唽 氚� 鞁滊Μ鞎� 鞚戈秾氩� 靹轨厴 219 氚� 歃濌秾瓯半灅氩� 靹轨厴 13(r)鞐� 霐半ジ 瓿奠嫓臧� 韽暔霅橃柎 鞛堨潓鞚� 鞎岆Μ電� 鞝曣赴 韱奠毳� 鞝勲嫭頄堨姷雼堧嫟. 鞚� 靹滍暅鞚� 攵�靷灔 瓴� 旮�搿滊矊 旎姼搿る煬 氚� 斓滉碃須岅硠毂呾瀯鞛愳澑 Denise L. Blomquist臧� 靹滊獏頄堨溂氅�, 10-K鞐� 鞏戈笁霅� 鞚措瀫 甏�霠� 頇滊彊鞐� 雽�頃� SEC鞐� 鞎岆Μ電� 氩曥爜 鞚橂毳� 鞚错枆頃╇媹雼�. 鞚� 韱奠鞐愲姅 甑泊鞝侅澑 靾橃箻雮� 瓯半灅 雮挫棴 靹る獏鞚� 韽暔霅橃柎 鞛堨 鞎婌晞 韴瀽鞛愲摛鞚� 鞛愳劯頃� 雮挫毄鞚� 頇曥澑頃橁赴 鞙勴暣 鞝勳泊 10-K 氤搓碃靹滊ゼ 彀胳“頃挫暭 頃╇媹雼�.
Medtronic plc (MDT) a adress茅 une notification de routine 脿 la Securities and Exchange Commission des 脡tats-Unis, indiquant que son rapport annuel sur le formulaire 10-K pour l'exercice clos le 25 avril 2025, d茅pos茅 le 20 juin 2025, contient des informations divulgu茅es conform茅ment 脿 la section 219 de l'Iran Threat Reduction and Syria Human Rights Act de 2012 et 脿 la section 13(r) de l'Exchange Act. La lettre, sign茅e par la vice-pr茅sidente, contr么leur mondial et directrice comptable Denise L. Blomquist, remplit l'obligation l茅gale d'informer la SEC de toute activit茅 li茅e 脿 l'Iran mentionn茅e dans le 10-K. Cette notification ne fournit aucun d茅tail quantitatif ni description des transactions sous-jacentes, invitant les investisseurs 脿 consulter le rapport 10-K complet pour plus de pr茅cisions.
Medtronic plc (MDT) hat der US-B枚rsenaufsichtsbeh枚rde SEC eine routinem盲脽ige Mitteilung 眉bermittelt, in der angegeben wird, dass der Jahresbericht auf Formular 10-K f眉r das am 25. April 2025 endende Gesch盲ftsjahr, eingereicht am 20. Juni 2025, Angaben gem盲脽 Abschnitt 219 des Iran Threat Reduction and Syria Human Rights Act von 2012 sowie Abschnitt 13(r) des Exchange Act enth盲lt. Das Schreiben, unterzeichnet von Vizepr盲sidentin, Global Controller und Chief Accounting Officer Denise L. Blomquist, erf眉llt die gesetzliche Verpflichtung, die SEC 眉ber etwaige im 10-K diskutierte Iran-bezogene Aktivit盲ten zu informieren. Diese Mitteilung enth盲lt keine quantitativen Details oder Beschreibungen der zugrunde liegenden Transaktionen, weshalb Investoren aufgefordert werden, den vollst盲ndigen 10-K-Bericht f眉r Einzelheiten zu konsultieren.
FAQ
Why did Medtronic (MDT) file a Section 13(r) notice on June 20, 2025?
What period does the Medtronic 10-K with Iran disclosure cover?
Who signed the Section 13(r) notice for Medtronic?
Does the notice reveal financial impact of Medtronic's Iran-related activities?
What laws require Medtronic to file this notice?
